Dusquetide for the Treatment of Behcet's Disease

Summary

This is a clinical study to see if dusquetide can treat flares of oral and genital ulcers caused by Behcet's Disease. Study participants will receive an infusion of dusquetide twice a week for 4 weeks (8 treatments total), with weekly follow-up visits for an additional 4 weeks.

Timeline

Start

2024-11-18

Primary completion

2025-05-23

Completion

2025-06-17

Publications

• Donini O, Sulu B, Pullion C, Rumage A, Straube R, Schaber C, Hatemi G. Results from a pilot study of dusquetide for the treatment of aphthous ulcers associated with Behcet's syndrome. Rheumatology (Oxford). 2026 Feb 4;65(2):keaf682. doi: 10.1093/rheumatology/keaf682.

Drugs

Indications